'Antibiotic resistance breaker' set for phase III trials

Scientists have announced what they say is a "major breakthrough" in the fight against antibiotic resistance, after a new compound combined with an existing antibiotic has proven successful in phase II trials.Antibiotic resistance is defined as an infection that does not respond to a particular drug, as a result of bacteria changes that make the infection immune to the drug.Scientists say a compound called HT61 has proven successful in phase II trials at boosting the effectiveness of old antibiotics against drug resistance.Drug-resistant bacteria is a global concern.

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/II6fDgdMMks/268842.php

auto sport medical rehab